VJHemOnc Podcast

COSTEM: maintenance therapies for FLT3+ AML


Listen Later

The FMS-like tyrosine kinase 3 (FLT3) gene is mutated in approximately 30% of patients with acute myeloid leukemia (AML) and...
...more
View all episodesView all episodes
Download on the App Store

VJHemOnc PodcastBy VJHemOnc

  • 4.5
  • 4.5
  • 4.5
  • 4.5
  • 4.5

4.5

2 ratings